# Meridian Bioscience to acquire GenePOC's molecular diagnostics business

Debiopharm announced that its subsidiary GenePOC has reached an agreement for Meridian Bioscience to acquire GenePOC's molecular diagnostics business portfolio, including the revogene device and rapid molecular assays.

- Type: Acquisition
- Announced: 2019-04-30
- Status: announced
- Products: molecular diagnostics, revogene device, rapid molecular assays
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Meridian Bioscience](https://endata.com/companies/39174.md) (acquirer)
- [GenePOC](https://endata.com/companies/39175.md) (target)
- [Debiopharm](https://endata.com/companies/39176.md) (partner)

## Sources

- [debiopharm.com](https://www.debiopharm.com/press-release/genepoc-a-subsidiary-of-debiopharm-group-reaches-an-agreement-with-meridian-bioscience-for-the-acquisition-of-their-molecular-diagnostics-business/), 2019-04-30: "Meridian Bioscience has a long, proven history in both the laboratory diagnostics and life sciences markets."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.